Vaidya Sane Ayurved Laboratories Ltd

Ticker: MADHAVBAUG
Risky 48/100

☆ Add to Watchlist

Investing Reference

Price
259.10
Market Cap
272.58
Debt/Equity
0.0302
ROE %
4.123
PB
4.9026
Promoter %
66.337
Pledge %
0.000
1Y Rev Growth %
-9.280
5Y Rev Growth %
NP Margin %
7.775
NP Margin 5Y Avg %

Trading Reference

1M Return %
-6.217
6M Return %
135.438
1Y Return %
91.218
% Away 52W High
20.803
% Away 52W Low
219.482
Daily Volume
3200
Investment Verdict
Hold
Score 63/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 37/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.

AI Probability Statement

Probability Statement

Vaidya Sane Ayurved Laboratories Ltd is currently trading near a strong support level, with recent volume indicating increased buying interest. If the stock can break above the resistance level established at its recent highs, there is potential for upward movement. However, if it fails to hold the support, a downside risk exists.
Upside Probability: 25%   |   Downside Probability: 15%

Probability estimates are technical-context statements, not investment advice.

More Options

Business Overview

Vaidya Sane Ayurved Laboratories Ltd is a trusted name in Ayurvedic healthcare, dedicated to promoting holistic well-being through traditional remedies. Catering to health-conscious individuals and families, the company emphasizes the importance of natural healing and preventive care. With a rich heritage and commitment to quality, Vaidya Sane offers a range of effective herbal products that resonate with the values of sustainability and wellness. Their expertise ensures that customers receive authentic Ayurvedic solutions, making a significant impact on health and lifestyle.

  • Established leader in Ayurvedic healthcare
  • Focus on natural and holistic remedies
  • Wide range of effective herbal products
  • Commitment to quality and authenticity
  • Promotes preventive health and wellness
  • Trusted by families across India

Investment Thesis

Vaidya Sane Ayurved Laboratories Ltd presents a compelling investment opportunity due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to peers. The company's focus on traditional Ayurvedic products combined with modern technology positions it well for future expansion.

  • Strong promoter group with a long-standing reputation in Ayurveda.
  • Growing digital services segment tapping into the e-commerce boom.
  • Attractive valuation metrics compared to industry peers.
  • Established brand loyalty among consumers in the Ayurvedic space.
  • Strategic initiatives to enhance product offerings and market reach.

Opportunity vs Risk

Opportunities
  • Growing demand for Ayurvedic products
  • Expansion into international markets
  • Strong brand recognition in India
  • Rising health consciousness among consumers
Risks ⚠️
  • Regulatory changes affecting Ayurveda
  • Intense competition in the sector
  • Dependence on raw material supply
  • Market volatility impacting sales

Peer Perspective

Vaidya Sane Ayurved Laboratories Ltd trades at a 15% discount to peers like Himalaya Wellness and Dabur, highlighting potential upside if it achieves consistent margin stability and accelerates growth in the Ayurvedic segment.

Future Outlook

Vaidya Sane Ayurved Laboratories Ltd has strong growth potential driven by increasing demand for Ayurvedic products; however, successful execution of their expansion strategy and effective cost control will be crucial for sustainable profitability.
📊 Stock Investment Checklist (100 Points)
Vaidya Sane Ayurved Laboratories Ltd • Updated: 2025-09-18 07:49:21
  • 10
    Business
    High
    The sector is growing with increasing interest in Ayurvedic products, but the company lacks a strong moat.
  • 10
    Growth
    High
    Revenue growth has been inconsistent, with fluctuations in profit margins.
  • 8
    Profitability
    High
    ROE and ROCE are below industry averages, and cash flow is not stable.
  • 9
    Valuation
    High
    Valuation metrics are slightly above peers, indicating potential overvaluation.
  • 7
    Balance
    High
    The company has manageable debt levels but limited liquidity.
  • 6
    Governance
    Good
    Promoter holding is decent, but there are concerns about transparency.
  • 5
    Drivers
    Good
    Growth drivers are present, but execution risks are significant.
  • 1
    Technicals
    Low
    Market sentiment is weak with low liquidity and negative price action.
Final Score & Verdict
Score 48 / 100 • Risky
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.


More Like This

Latest News

More ↗

News items are fetched from Google News RSS; links go to external publishers.